Nurse Practitioner · Glendale, CA
NPI
1548765225
Since 2018
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1505 Wilson Ter Ste 155
Glendale, CA, 91206
Phone (818) 500-4055
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$774K
1,875 prescriptions
Company payments, 2025
$800
From 5 companies
Medicare prescription drug claims, 2024
In 2024, the drug Noralie P Raudszus prescribed most often to Medicare patients was Prosol (Parenteral Amino Acid 20% No.1), with 376 prescriptions and refills. In total Noralie P Raudszus wrote 1,875 Medicare prescriptions that cost $774K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-28.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Prosol Parenteral Amino Acid 20% No.1 | 376 | 376 | 12 | $56K |
| Sevelamer Carbonate Generic | 166 | 262 | 38 | $98K |
| Furosemide Generic | 128 | 174 | 23 | $672 |
| Hydralazine Hcl Generic | 105 | 171 | 30 | $926 |
| Calcium Acetate Generic | 93 | 164 | 25 | $8,941 |
| Clinisol Parenteral Amino Acid 15% No.5 | 80 | 80 | Under 11 | $16K |
| Amlodipine Besylate Generic | 63 | 107 | 14 | $146 |
| Sevelamer Hcl Generic | 54 | 115 | 11 | $75K |
| Nifedipine Er Nifedipine | 54 | 97 | 16 | $536 |
| Velphoro Sucroferric Oxyhydroxide | 52 | 68 | 11 | $152K |
| Atorvastatin Calcium Generic | 45 | 72 | Under 11 | $118 |
| Gabapentin Generic | 39 | 55 | Under 11 | $119 |
| Allopurinol Generic | 34 | 58 | Under 11 | $84.65 |
| Carvedilol Generic | 29 | 45 | Under 11 | $93.1 |
| Veltassa Patiromer Calcium Sorbitex | 29 | 38 | 12 | $34K |
Brand drugs: 669 claims; generic drugs: 1,206 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Noralie P Raudszus $800 ($800 in general payments such as food, travel and fees) from 5 companies. The largest payer was Akebia Therapeutics Inc with $348.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.